drugset / Trial / NCT03617783

Prebiotic Treatment in People With Schizophrenia - Pilot Study

NCT03617783 ↗

Phase 4 Completed 26 enrolled University of Maryland, Baltimore
RandomizedParallel-groupQuadruple-blindOther

Summary

The purpose of this study is to examine changes in serum butyrate levels with the prebiotic: Prebiotin (12g/day), an oligofructose-enriched inulin (OEI); the effect of OEI on the composition of the gastrointestinal microbiota in people with schizophrenia; and the relationship of the composition of the gut microbiota to various clinical, cognitive, and neuroimaging variables.

Timeline

Start
2019-07-18
Primary completion
2022-04-05
Completion
2022-04-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prebiotin Other / unclassified 4 g —